BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/11/2025 8:40:29 AM | Browse: 18 | Download: 59
Publication Name World Journal of Clinical Urology
Manuscript ID 109933
Country China
Received
2025-05-26 01:06
Peer-Review Started
2025-05-26 01:06
To Make the First Decision
Return for Revision
2025-06-10 07:12
Revised
2025-06-21 11:33
Second Decision
2025-07-29 02:33
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-07-29 08:03
Articles in Press
2025-07-29 08:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-08-07 02:29
Publish the Manuscript Online
2025-08-11 03:06
ISSN 2219-2816 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Basic Study
Article Title β-elemene inhibits bladder cancer cell through the expression of cell membrane protein GM3
Manuscript Source Unsolicited Manuscript
All Author List Fang-Yin Li, Ying Wang and Yong-Jun Zhang
Funding Agency and Grant Number
Funding Agency Grant Number
the Zhejiang Provincial Traditional Chinese Medicine Foundation No. 2021ZA021; and No. 2022ZZ005
Corresponding Author Yong-Jun Zhang, Associate Chief Physician, Department of Integration of Traditional Chinese and Western Medicine, Zhejiang Cancer Hospital, No. 1 Banshan Eastern Road, Hangzhou 310022, Zhejiang Province, China. zhangyongjun770323@163.com
Key Words Beta-elemene; Bladder cancer; EGFR; GM3; Malignancy
Core Tip We believe that our study makes a significant contribution to the literature because GEPIA2 database deep mining revealed that GM3 was poorly expressed in bladder cancer (BLCA), and this study showed that beta-elemene inhibited BLCA cells by increasing GM3 expression. Moreover, cluster analysis showed that GM3 increased cell adhesion and inhibited the invasion and migration of BLCA cells by expressing membrane-related signaling proteins. Further, we believe that this paper will be of interest to the readership of your journal because the use of beta-elemene in anti-cancer medication is advantageous owing to its significant anti-tumor activity against various types of cancer and its reduced toxicity, which ensures that its impact on the quality of life of patients with cancer is minimal and the drug is well tolerated. Thus, this study provides a preliminary basis and strong evidence for further research on the underlying molecular mechanisms of beta-elemene in the treatment of BLCA.
Publish Date 2025-08-11 03:06
Citation <p>Li FY, Wang Y, Zhang YJ. β-elemene inhibits bladder cancer cell through the expression of cell membrane protein GM3. <i>World J Clin Urol</i> 2025; 14(2): 109933</p>
URL https://www.wjgnet.com/2219-2816/full/v14/i2/109933.htm
DOI https://dx.doi.org/10.5410/wjcu.v14.i2.109933
Full Article (PDF) WJCU-14-109933-with-cover.pdf
Manuscript File 109933_Auto_Edited_070841.docx
Answering Reviewers 109933-answering-reviewers.pdf
Audio Core Tip 109933-audio.mp3
Biostatistics Review Certificate 109933-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 109933-conflict-of-interest-statement.pdf
Copyright License Agreement 109933-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 109933-foundation-statement.pdf
Institutional Review Board Approval Form or Document 109933-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 109933-non-native-speakers.pdf
Peer-review Report 109933-peer-reviews.pdf
Scientific Misconduct Check 109933-scientific-misconduct-check.png
Scientific Editor Work List 109933-scientific-editor-work-list.pdf
CrossCheck Report 109933-crosscheck-report.pdf